Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: Clinical analysis and characterisation of viral genome

The Lancet

Volumn 381, Issue 9881, 2013, Pages 1916-1925

  Chen, Yu ^a   Liang, Weifeng ^a   Yang, Shigui ^a   Wu, Nanping ^a   Gao, Hainv ^a   Sheng, Jifang ^a   Yao, Hangping ^a   Wo, Jianer ^a   Fang, Qiang ^a   Cui, Dawei ^a   Li, Yongcheng ^b   Yao, Xing ^c   Zhang, Yuntao ^a   Wu, Haibo ^a   Zheng, Shufa ^a   Diao, Hongyan ^a   Xia, Shichang ^d   Zhang, Yanjun ^d   Chan, Kwok Hung ^e   Tsoi, Hoi Wah ^e   Teng, Jade Lee Lee ^e   Song, Wenjun ^e   Wang, Pui ^e   Lau, Siu Ying ^e   Zheng, Min ^e   Chan, Jasper Fuk Woo ^e   To, Kelvin Kai Wang ^e   Chen, Honglin ^a,e   Li, Lanjuan ^a   Yuen, Kwok Yung ^a,e   more..

^a ZHEJIANG UNIVERSITY   (China)

^b Xiaoshan District Sixth People's Hospital   (China)

^c HUZHOU CENTRAL HOSPITAL   (China)

^d ZHEJIANG PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; C REACTIVE PROTEIN; COMPLEMENTARY DNA; CREATINE KINASE; D DIMER; GLUTAMINE; GLYCINE; INTERLEUKIN 10; LACTATE DEHYDROGENASE; OSELTAMIVIR; SERINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; AVIAN INFLUENZA A H7N9; AVIAN INFLUENZA VIRUS; CASE REPORT; CLOACA; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DNA SYNTHESIS; DUCK; FEMALE; FEVER; GENE MUTATION; HUMAN; INFLUENZA A; INFLUENZA A (H7N9); KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIVER FUNCTION; LUNG INFILTRATE; LYMPHOCYTOPENIA; MALE; MIXED INFECTION; PHYLOGENETIC TREE; PNEUMONIA; POULTRY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SPUTUM ANALYSIS; SYMPTOM; THROAT CULTURE; VIRUS GENOME; VIRUS ISOLATION;

EID: 84878336274     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60903-4     Document Type: Article

References (30)

1. To KK, Ng KH, Que TL, et al. Avian influenza A H5N1 virus: a continuous threat to humans. Emerg Microbes Infect 2012; 1: e25.
2. Yuen K Y, Chan PKS, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351: 467-71.
3. Arzey GG, Kirkland PD, Arzey KE, et al. Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia. Emerg Infect Dis 2012; 18: 814-16.
4. Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004; 363: 587-93.
5. Ostrowsky B, Huang A, Terry W, et al. Low pathogenic avian influenza A (H7N2) virus infection in immunocompromised adult, New York, USA, 2003. Emerg Infect Dis 2012; 18: 1128-31.
6. Tweed SA, Skowronski DM, David ST, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 2004; 10: 2196-99.
7. Cheng VC, Chan JF, Wen X, et al. Infection of immunocompromised patients by avian H9N2 influenza A virus. J Infect 2011; 62: 394-99.
8. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
9. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
10. Estenssoro E, Reina R, Canales HS, et al. The distinct clinical profile of chronically critically ill patients: a cohort study. Crit Care 2006; 10: R89.
11. Li IW, Chan KH, To K W, et al. Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. J Clin Virol 2009; 46: 325-30.
12. To KK, Hung IF, Li IW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010; 50: 850-59.
13. Chen H, Smith GJ, Li KS, et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci USA 2006; 103: 2845-50.
14. Peiris JSM, Lai ST, Poon LLM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361: 1319-25.
15. Chan JF, Li KS, To KK, Cheng VC, Chen H, Yuen KY. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect 2012; 65: 477-89.
16. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367: 1814-20.
17. De Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12: 1203-07.
18. Li KS, Xu KM, Peiris JS, et al. Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol 2003; 77: 6988-94.
19. Law AH, Lee DC, Yuen KY, Peiris M, Lau AS. Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction. Cell Mol Immunol 2010; 7: 263-70.
20. Hung IF, To KK, Lee CK, et al. Hyperimmune intravenous immunoglobulin treatment: a multicentre double-blind randomized controlled trial for patients with severe A(H1N1)pdm09 infection. Chest 2013; published online Feb 28. DOI:10.1378/chest.12-2907.
21. Zheng BJ, Chan KW, Lin YP, et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci USA 2008; 105: 8091-96.
22. Cheng VC, To KK, Tse H, Hung IF, Yuen KY. Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev 2012; 25: 223-63.
23. Zhang AJ, To KK, Li C, et al. Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. J Infect Dis 2013; 207: 1270-80.
24. Feng Y, Kong Y, Barnes PF, et al. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Immun 2011; 79: 229-37.
25. Sturm-Ramirez KM, Hulse-Post DJ, Govorkova EA, et al. Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J Virol 2005; 79: 11269-79.
26. Chen LM, Blixt O, Stevens J, et al. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology 2012; 422: 105-13.
27. Zhou H, Yu Z, Hu Y, et al. The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus. PLoS One 2009; 4: e6277.
28. Steel J, Lowen AC, Mubareka S, Palese P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog 2009; 5: e1000252.
29. Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013; published online April 11. DOI:10.1056/NEJMoa1304459.
30. Hai-bo W, Ru-feng L, En-kang W, et al. Sequence and phylogenetic analysis of H7N3 avian influenza viruses isolated from poultry in China in 2011. Arch Virol 2012; 157: 2017-21.